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Telehealthcare for long term conditions
Susannah McLean,1 Denis Protti,2 Aziz Sheikh1
Telehealthcare is the provision of personalised health­
care over a distance.1 It has the three following essential 
co mponents2 w1:
• The patient provides data such as a voice recording, 
video, electrocardiography, or oxygen saturation that 
gives information about the illness.
• Information is transferred electronically to a 
healthcare professional at a second location.
• The healthcare professional uses clinical skills and 
judgment to provide personalised feedback tailored to 
the individual.
Telehealthcare can be delivered by both synchronous 
and asynchronous (such as store and forward) technologies 
(fig 1). For example, telephone and video conferencing ena­
ble consultations in real time. An example of asynchronous 
communication would be storing two weeks’ of spirometry 
results in a batch and forwarding these on to a healthcare 
provider, who responds by email or telephone. 
Telehealthcare is related to, but distinct from tele­
medicine, where technology is used to share information 
over a distance between healthcare providers.2
Why is interest in telehealthcare increasing?
Healthcare systems globally are facing major challenges 
such as ageing populations, increasing numbers of p eople 
living with long term conditions, patients in remote areas 
or with limited mobility, and increasing  expectations for 
patient centred healthcare.w2 w3 Telehealthcare offers 
potential solutions to these challenges (see box 1),3 
but the acceptability and effectiveness, and the safety 
 considerations associated with its adoption need careful 
 consideration.
Acceptability to professionals and patients
Professionals
Telehealthcare can greatly alter the healthcare encoun­
ter. In the United States there was some resistance to 
ad opting telehealthcare until state insurers (such as 
Medicare) recognised it as a reimbursable medical act. 
A similar reimbursement related barrier has been seen 
in parts of the European Union.w4 In fact, in countries 
with insurance based health systems, collocation of 
patient and practitioner was sometimes a requirement 
for reimbursement.w4 However, the European Commis­
sion now regards t elehealthcare as a legitimate medical 
act, drawing attention to the points listed in box 2.w5
SUMMARY POINTS
Telehealthcare is personalised healthcare delivered over a distance; data are transferred 
from the patient to the professional, who then provides feedback
In patients with severe long term conditions, such as problematic asthma and diabetes, 
telehealthcare can reduce hospital admissions without increasing mortality
Potential pitfalls include user interface problems, technical problems, and safety concerns 
such as data loss and confidentiality
Telehealthcare can alter the doctor-patient relationship so try to humanise the interaction 
Consider workflows, to minimise unintended disruptions to normal routines
Careful assessment of effectiveness, cost effectiveness, and safety considerations is 
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Fig 1 | Key elements of telehealthcareSOURCES AND SELECTION CRITERIA
We identified systematic reviews and original research 
studies on telehealthcare and long term conditions. We used 
searches from our ongoing Cochrane systematic reviews 
to find randomised controlled trials for telehealthcare 
interventions for asthma and chronic obstructive 
pulmonary disease. Search terms were telehealth, tele-
health, telemedicine, tele-medicine, internet, computer, 
web, interactive, telecommunication, telephone, phone, 
SMS, tele-monitor, telemonitor, telemanagement, tele-
management, teleconsultation, tele-consultation, telecare, 
tele-care, telematic, telepharmacy, and tele-pharmacy. We 
searched PubMed (1948 to March 2010) using search terms 
telehealthcare, telehealth, telecare, telemedicine, systematic 
review or randomised controlled trial, and selected relevant 
studies from these.
We searched the internet for so called grey literature, 
including legal and strategic documents, and official 
government healthcare websites. We also used our private 
libraries of research papers and completed and ongoing work 
on telehealthcare.
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Patients
Patients’ attitudes to telehealthcare have been extensively 
studied. A 2007 systematic review of patients with a range 
of long term conditions found that most patients saw 
t elehealthcare as a positive development.3 Telehealthcare 
improves access to care, which increases patients’ under­
standing of their condition and can lead to a greater sense of 
empowerment and willingness to engage with self care.3 4
Telehealthcare is not just suited to the technologically lit­
erate. A 1998 study of people with little experience of tech­
nology using a new asthma telehealthcare system daily for 
three weeks found that 88% of them felt safer while being 
monitored by the system; 94% were interested in using the 
same system in the future.5
Descriptive studies provide only limited data on patients’ 
and carers’ perspectives on these new models of care. A 
2000 systematic review found that despite a large body of 
literature on patients’ satisfaction with te lehealthcare, the 
research lacked depth. The authors urged caution when 
interpreting the largely positive findings reported in many 
studies.6
Qualitative approaches can generate a more rounded, 
nuanced appreciation of patients’ experiences and expec­
tations. A 2009 study convened a so called citizens’ panel 
to help understand patients’ perspectives on telehealth­
care.7 The panel discussions generated important insights. 
Although the policy discourse on telehealthcare is full of 
positive references to a shift in the patient’s role from pas­
sive to active—becoming “informed,” “expert,” and “self 
managing”—the panel thought that existing power rela­
tionships were often reinforced, with passive patients being 
monitored by a now distant medical professional. They also 
concluded that telehealthcare could not take the place of 
face to face interaction and that a combination of face to face 
and telehealthcare consultations was optimal. The panel 
emphasised the need for increased discourse with the pub­
lic regarding the boundaries for these technologies, because 
of a concern that t elehealthcare could take attention away 
from personal care needs. However, the panel recognised 
that such interventions could potentially make a valuable 
contribution to modern healthcare provision so long as the 
patient still had the option of face to face care, if required.
Other qualitative studies have identified similar concerns. 
The subjects in a 2008 study registered some annoyance 
with their partner or informal carer for being “too con­
cerned” during a period of telehealthcare in the home. Inter­
views with the partners showed that they felt “forced to take 
responsibility,” despite feeling insecure and worried because 
they lacked confidence in the technology.w6 More positively, 
patients also described feeling secure with telehealthcare 
and described being “looked after” at home. They also expe­
rienced “freedom” in contrast to being “under surveillance” 
while in h ospital.
Age and cognitive function are relevant when considering 
the acceptability of telehealthcare to different populations. 
Incipient dementia or mental health problems can affect 
patients’ ability to use the technology. As vision, hearing, 
and dexterity change with age, even mentally competent 
older people may struggle with the technology. Further, 
setting up systems that increase the social isolation of this 
group of vulnerable people is a concern. Each individual’s 
suitability for telehealthcare interventions needs to be care­
fully considered.w7 w8
Effectiveness and cost effectiveness
Effectiveness
The effectiveness of telehealthcare is often assumed by 
industry and policymakers.8 However, effectiveness 
depends on the context of the introduction of a specific 
system. The aim of introducing telehealthcare must be 
clear from the start.9 Such aims might be to widen access, 
improve clinical end points, aid the early detection of dis­
ease exacerbations, reduce the risk of hospital admissions, 
reduce mortality, or reduce the degree of dependency in 
old age. Agreement on why telehealthcare has been intro­
duced, followed by focused implementation and evalua­
tion to see if the specific need has been dealt with, helps 
determine when and if aims have been realised.
Several examples of clinically successful telehealthcare 
projects exist (see box 3 for an example in patients with 
Box 1 | How might telehealthcare systems benefit patients?3
Allows patients to be cared for in their preferred location, typically at home
Provides patient education and support for preventive care in, for example, those trying to 
lose weight
Videophone or web based clinical consultations, such as those for asthma or chronic 
obstructive pulmonary disease, or diabetes annual reviews, can replace routine visits such 
as face to face annual reviews
Improves adherence to drugs and other treatments
Proactive education and support, such as via web forums, may facilitate self management 
and help with coping (for example, in people with chronic back pain) or prevent 
exacerbations of conditions such as asthma
Use of monitoring techniques can enable earlier detection of disease exacerbations, thereby 
facilitating timely management and support
Allows greater opportunities for continuity of care with the same clinician and more frequent 
assessments
Reduces costs to patients by obviating the need for time off school or work and for travel
Box 2 | Summary of the European Economic and Social Committee’s opinion on 
telehealthcarew5
Telehealthcare cannot and should not replace conventional medicine. It is a complementary 
technique, limited by the absence of clinical examinations.
The status of the health practitioner should be clearly indicated
The patient must benefit from the latest medical knowledge
The patient must be able to give his or her free consent
Medical confidentiality must be ensured
Resulting documents must be secure and recorded in the medical file
Continuity of care must be ensured
The medical act must be of at least equivalent quality to a traditional act
Box 3  | An example of a successful telehealthcare intervention in type 2 diabetes13 14
The IDEATel trial (http://clinicaltrials.gov/ct2/show/NCT00271739) found that when 
people monitored their blood glucose and blood pressure with telehealthcare input from 
specialist nurses and endocrinologists, their glycated haemoglobin decreased, as did their 
blood pressure, and low density lipoprotein-cholesterol. All cause mortality was similar in 
the intervention and control arms of the trial. The study was not powered to find differences 
in mortality from cardiovascular disease.
Further analysis showed that improvement in self efficacy in older ethnically diverse 
patients with diabetes resulted in an improvement in glycaemic control. The telehealthcare 
intervention had a direct effect and an indirect effect—mediated by a change in self-
efficacy—on glycaemic control. Blood pressure and low density lipoprotein-cholesterol 
improved, but this effect was not mediated by a change in self efficacy.
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diabetes). In chronic obstructive pulmonary disease, inter­
ventions with a dedicated chronic obstructive pulmonary 
disease case manager have reduced the numbers of exacer­
bations and related admissions to hospital.10­12 For example, 
in one trial, case managers provided an enhanced service 
during working hours, monitoring patients with increased 
frequency using media including video conferencing (see 
fig 2). In a 2003 trial of patients with chronic obstructive 
pulmonary disease related respiratory failure requiring long 
term oxygen therapy or mechanical ventilation, or both, 
case managers alternated physical visits to the patient’s 
home with virtual home visits via telehealthcare to conduct 
reviews and reduce the need for admission.10
Our systematic review identified several telehealthcare tri­
als in asthma with similar findings.15 It found little e vidence 
of improvements in measures of disease specific quality of life 
in most patients with mild or moderate disease, but hospital 
admissions were reduced in carefully selected patients who 
had severe asthma or had recently been admitted to hospital 
(or both) and are consequently at high risk of readmission.15
A 2009 systematic review found that telehealthcare for 
people with diabetes can help improve glycaemic control.16 
The number of admissions to hospital and the length of stay 
associated with admission were reduced. People with more 
severe problems benefitted most from the regular t ailored 
feedback.6 The data suggested that outcomes were more 
likely to improve if these contacts helped establish and 
maintain the continuity of a close therapeutic relationship. 
Patients were likely to become better at self management and 
increase their self efficacy so that, over time, they depended 
less on feedback.13 16 Conversely, patients with high baseline 
self efficacy may be less likely to benefit from a management 
regimen that involves frequent testing and reporting.
Overall, the evidence shows that telehealthcare based 
initiatives may be particularly helpful for people with acces­
sibility problems, or where a need for careful monitoring and 
regular feedback has been identified, or both. These newer 
models of care seem to be less effective in p eople with rela­
tively mild disease and those in whom control is already 
considered optimal.13 15­17
Cost effectiveness
Evidence suggests that only some classes of low cost 
t elehealthcare interventions in certain contexts (such 
as  telephone follow­up to improve attendance or text 
m essaging reminders for monitoring) are likely both to 
improve outcomes and reduce costs.18 Overall, the evi­
dence for cost effectiveness is limited. Where studies 
have been conducted, they were often short term or did 
not consider the full range of perspectives (those of the 
patient, healthcare provider, and society). There are only 
a limited number of more detailed analyses, such as cost­
utility analysis or estimations of opportunity costs.14 w9­w11
Safe implementation
Protocols and procedures
Professionals and their respective bodies have been hesi­
tant to introduce telehealthcare partly because of safety 
concerns. The worry is that specialist emergency care might 
be precluded for an ill patient managed outside of the hos­
pital environment—as in the case of a patient experiencing 
an exacerbation of chronic obstructive pulmonary disease, 
for example—should an unpredictable acute deterioration 
occur. However, in most cases acute deterioration can be 
anticipated, and the death rates of patients managed in the 
community are, so far as has been demonstrated in trials, 
not higher than those managed in hospital.19 20 This concern 
helps to explain the increased intensity of monitoring when 
telehealthcare systems are introduced into people’s homes. 
Frequency of contact is often necessary to gain the confi­
dence of both patients and healthcare professionals using 
the technologies. However, to tackle these concerns more 
research with full reporting of adverse events is needed.
Access to healthcare professionals via telephone, email, 
and the internet or other networked interventions may lead 
to breaches of confidentiality or loss of electronic data (or 
both), as has been illustrated by several recent high profile 
cases.w12 w13 Appropriate encryption software should be used 
and secure data transfer built into systems. Doctors should 
follow the advice from national professional regulatory bod­
ies on telephone and email consulting, such as the General 
Medical Council’s advice for UK practitioners (box 4).w14
More fundamentally, doctors need to consider whether 
a remote consultation is appropriate in the first place. Most 
defence unions emphasise that no email, text m essage, 
or telephone consultation is a substitute for a stand­
ard face to face consultation and examination.21 w15 w16 
In the UK, general practices are contractually obliged 
Fig 2 | Telehealthcare with video conferencing for a patient 
with chronic obstructive pulmonary disease
Box 4 | Remote prescribing guidance from the UK General 
Medical Councilw14
In all circumstances, ensure that you have an appropriate 
dialogue with the patient to:
• Establish the patient’s history and current medical 
conditions and current or recent use of drugs, including non-
prescription ones
• Carry out an adequate assessment of the patient’s condition
• Identify the likely cause of the patient’s condition
• Ensure that there is sufficient justification to prescribe the 
drugs or treatment proposed. Where appropriate discuss 
other treatment options with the patient
• Ensure that the treatment or drug(s) are not contraindicated 
for the patient
• Make a clear, accurate, and legible record of all drugs 
prescribed
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to offer patients a physical examination if considered 
 appropriate.
Workflow changes
The potential for disruption to existing workflow patterns 
should not be underestimated and is a major factor in the 
failure of many IT based service redesigns.22 23 Healthcare 
professionals need to have protected time and resources 
to respond to the work generated by telehealthcare. More 
broadly, a theoretical framework such as normalisation 
process theory can help identify the barriers to change in 
this type of situation.w17 
For example, consider the implications of a trial of a 
telehealthcare intervention in patients with chronic heart 
failure in which patients monitored their own weight 
and blood pressure and recorded their own electrocar­
diogram to transmit to a hospital based specialist nurse. 
The nurse, in consultation with a cardiologist, provided 
tailored advice to the patient over the telephone on man­
aging the illness.w18 
Several important workflow points were highlighted:
• The role and responsibility of the nurse has changed; 
nurses are increasingly involved in decision making, 
which requires further training.
• The general practitioner is somewhat marginalised, 
because patients with increasingly complex 
management regimens default to a trusted specialist 
relationship.
• There is a need to maintain accountability; this can 
be achieved by protocols and guidelines for case 
managers, describing how much they can undertake 
themselves and when to involve a senior medical 
practitioner, though such protocols and guidelines 
may prove burdensome.
Training of staff and patients
The integration of telehealthcare into health service 
workflows often means adding to the roles and respon­
sibilities of healthcare professionals. This was the case 
in the Columba telehealthcare initiative,w19 where exten­
sive protected training opportunities had to be provided 
for staff. During these sessions, staff learnt how to use 
the technologies and in turn contributed ideas for the 
 adaptation and integration of the technologies into exist­
ing workflow patterns.
Patients may also need training. Ideally, to help establish 
trust and confidence, the first interaction of a telehealthcare 
system should be face to face. Training should be tailored 
to patients’ baseline familiarity with technology. Once con­
fident with using the technology, patients can continue to 
operate it independently (see fig 3).
Looking ahead, future research should seek to understand 
how best to humanise the remote relationship and find ways 
of maintaining and, if possible, enhancing the all important 
therapeutic relationship.w5 
Conclusions
Telehealthcare based interventions are proliferating rap­
idly and are underpinned by variable quality of evidence. 
To implement telehealthcare effectively and safely, the 
aims of introducing telehealthcare to a care process must 
be clear. Such aims might be to improve access, increase 
satisfaction, avoid emergency admissions, or reduce 
costs. Less complex interventions, such as those based 
on the telephone, have a more robust evidence base, 
but even with such established technologies healthcare 
providers must remain vigilant to the dangers of compro­
mising safety in the absence of a face to face consulta­
tion.24 Contextual factors such as type of illness, type of 
technology, age, and ability of the patients to interface 
with technology must be considered. Robust cost­ benefit 
evaluations must be performed before making these 
technologies mainstream, to avoid increased cost and 
 widespread disappointments.25 w20
Fig 3 | Once confident with using the technology, patients can 
continue to operate it independently
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CASE REPORT
Neck lump in a young woman
1  Local symptoms such as voice changes, a nodule in a child, cervical lymphadenopathy, rapid 
enlargement, or stridor should prompt urgent referral.
2  In a young euthyroid patient, a neoplastic thyroid lesion should be excluded first. Other differential 
diagnoses include lumps of non-thyroid origin (branchial cyst, cystic hygroma, parotid tumour, 
laryngocele, carotid body tumour) and thyroid origin (toxic goitre and non-toxic goitre, both of which 
are unlikely in this euthyroid patient).
3  Fine needle aspiration is the investigation of choice for a definitive histological diagnosis.
4  Ultrasound of the neck will help localise the anatomical origin, and measurement of serum 
calcium and 24 hour urinary catecholamines might help rule out hyperparathyroidism and 
phaeochromocytoma, respectively.
5  Medullary thyroid cancer was confirmed by fine needle aspiration. If this is suspected, look for 
symptoms and signs of local invasion (dysphagia), metastasis, and the systemic effects of concurrent 
calcitonin and peptide secretion (frequent loose stools and vasomotor flushing). Medullary thyroid 
cancer may be sporadic, familial, or as part of the multiple endocrine neoplasia syndomes (MEN2A 
and MEN2B) so multiple endocrine neoplasia needs to be excluded too. Patients with established 
medullary thyroid cancer should undergo a total thyroidectomy and local neck dissection. Prognosis is 
good, with a 92% survival rate at 10 years.
STATISTICAL QUESTION
Meta-analyses V
Statements b and d are true, 
whereas a and c are false.
ON EXAMINATION QUIZ
Glasgow coma scale 
Patient 1 Score of 10 (eye 
opening to pain: 2; speaking, but 
incomprehensible: 3; localises to 
pain: 5)
Patient 2 Score of 3 (no responses 
for eye opening, speech, or pain: 
1 each (3))
Patient 3 Score of 13 (eye opening 
when asked: 3; confused speech: 
4; normal movements: 6)
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